ProMIS Neurosciences, Inc. (PMN)
NASDAQ: PMN · Real-Time Price · USD
8.16
-0.02 (-0.19%)
Jan 20, 2026, 4:00 PM EST - Market closed
ProMIS Neurosciences Market Cap
ProMIS Neurosciences has a market cap or net worth of $17.57 million as of January 21, 2026. Its market cap has decreased by -44.00% in one year.
Market Cap
17.57M
Enterprise Value
2.14M
1-Year Change
-44.00%
Ranking
Category
Stock Price
$8.16
Market Cap Chart
Since April 16, 2012, ProMIS Neurosciences's market cap has decreased from $21.82M to $17.57M, a decrease of -19.47%. That is a compound annual growth rate of -1.56%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jan 20, 2026 | 17.57M | 19.63% |
| Dec 31, 2025 | 14.69M | -52.59% |
| Dec 31, 2024 | 30.98M | 42.66% |
| Dec 29, 2023 | 21.72M | -41.67% |
| Dec 30, 2022 | 37.23M | -24.28% |
| Dec 31, 2021 | 49.17M | 104.73% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 929.76B |
| Johnson & Johnson | 526.82B |
| AbbVie | 378.84B |
| UnitedHealth Group | 299.85B |
| AstraZeneca | 289.32B |
| Novartis AG | 278.23B |
| Merck & Co. | 270.12B |
| Novo Nordisk | 261.50B |